The APS are pleased to announce a unique opportunity of a one-day event which will introduce the scientific principles underlying the use of cells and genetic material as therapeutic products. The design, delivery and manufacture of new medicines will be explored, along with the basis of clinical trials and the regulatory framework that guides their use.
This meeting will gather experts from academia and Pharmaceutical companies and will be ideal for those seeking to understand more about Advanced Therapeutic Products and the journey from initial concept to clinical use.
The event is suitable for those working in, and/or who have an interest in cell and gene therapy. It takes the attendee from the scientific principles of advanced therapeutics to their design, delivery, manufacture, clinical trial and the regulatory process. Experts in the respective areas will present and there will be opportunity for discussion and debate within a dynamic forum.
Postgraduate students working in the area may also wish to attend for whom there is a competitively priced attendance fee.
Visiting scientist, Robert Gordon University, Aberdeen, Scotland.
Associate Principal Scientist, Advanced Drug Delivery, Pharmaceutical Science, Research and Developement, Astra Zeneca.
Operational Excellence Director for the implementation of process improvement in the manufacturing of a wide portfolio ranging from small molecules to ATMPs, Takeda Pharmaceutical Company.
Zahra Rattray is a Chancellor’s research fellow and lecturer at the University of Strathclyde Institute of Pharmacy and Biomedical Sciences.
Lead R&I Pharmacist. Wythenshawe Hospital, MFT, Manchester,UK
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.